if switching from semaglutide to tirzepatide Switch What to Know When Switching

[ [PMID: 35015037] [ [PMID: 33854484] versus other GLP-1 RAs in patients with type 2 diabetes in a US real-world setting

This delays gastric motility to prolong feelings of satiety while improving enteric nutrient uptake and postprandial glucose levels

Instead, it works gradually, with noticeable changes typically appearing within 4 to 6 weeks

While not as commonly reported as other side effects like nausea, heartburn (and related issues like indigestion, belching, or acid reflux) can happen especially as your dose increases

How Rybelsus works Rybelsus mimics one hormone called GLP-1 (glucagon-like peptide-1), which: Slows food movement through your stomach, helping you feel fuller for longer Communicates with your brains appetite centre to reduce hunger Improves blood sugar control by enhancing insulin function Because semaglutide is a protein, it would normally be destroyed by stomach acid